Mesothelioma Patient Data and Treatment Decisions
| |

Mesothelioma Patient Data and Treatment Decisions

ByHolly Zink

A group of scientists published a study on mesothelioma data to find trends on how patients are being treated, and how long they survive. Scientists from the University of Pennsylvania have published a study on malignant pleural mesothelioma (MPM) in the journal Cancer Medicine. They looked at data from the National Cancer Database to find trends in who is getting MPM, how they are being treated, and how long they survive after diagnosis. Conventional Treatment Malignant pleural mesothelioma (MPM) is an aggressive cancer that grows in the cells lining the lungs. It is usually caused by exposure to asbestos at work or at home. MPM occurs in about 2,000 people in the United States every year. Rates of pleural mesothelioma…

Pleural Mesothelioma Rates Remain Stagnant As Survival Improves
| | |

Pleural Mesothelioma Rates Remain Stagnant As Survival Improves

ByAlex Strauss

A new report shows pleural mesothelioma rates in the US have failed to decline as they were predicted to do, but survival is improving slightly.  The US government began to implement tighter restrictions on asbestos in the 1970s. Researchers at the Cleveland Clinic say original projections had the incidence of pleural mesothelioma peaking in the early 2000s as a result. Pleural mesothelioma rates were supposed to decline after that. But numbers from the National Cancer Database (NCDB) tell a different story. They suggest that, while mesothelioma survival is improving, incidence of asbestos cancer are not. Asbestos and Malignant Mesothelioma Malignant mesothelioma is the most serious of a range of illnesses caused by asbestos. Pleural mesothelioma is the most common type…